P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE)

✍ Scribed by L. Gianni; T. Pienkowski; Y.-H. Im; L. Roman; L.-M. Tseng; M.-C. Liu; A. Lluch-Hernandez; V. Semiglazov; P. Valagussa; T. Szado

• Book ID: 114316638
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 37 KB
• Volume: 20
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(11)70241-7